<p>ICU 医疗（NASDAQ:ICUI - 获取免费报告）在周三发布给投资者的研究报告中，被 StockNews.com 从 “持有” 评级上调至 “买入” 评级。</p>
<p>其他一些分析师也对该公司发表了看法。杰富瑞金融集团在 10 月 14 日星期一发布的研究报告中开始覆盖 ICU 医疗。他们对该股票给予了 “持有” 评级，并设定了 183.00 美元的目标价。KeyCorp 在 11 月 13 日的研究报告中将 ICU 医疗的目标价从 198.00 美元上调至 209.00 美元，并给予该公司 “增持” 评级。Needham &amp; Company LLC 在 11 月 13 日的报告中重新发布了对 ICU 医疗股票的 “持有” 评级。最后，Raymond James 在 9 月 12 日的研究报告中将 ICU 医疗的目标价从 158.00 美元上调至 190.00 美元，并给予该股票 “跑赢大盘” 评级。两位分析师对该股票给予了持有评级，四位分析师则给予了买入评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 173.00 美元。</p>
<p><strong>查看我们关于 ICUI 的最新报告</strong></p>
<h2>ICU 医疗股票表现</h2>
<p>NASDAQ:ICUI 在周三开盘价为 169.70 美元。该股票的 50 日移动平均线为 176.59 美元，200 日移动平均线为 144.30 美元。ICU 医疗的 52 周低点为 82.82 美元，52 周高点为 196.26 美元。该公司的市值为 41.5 亿美元，市盈率为-37.13，贝塔值为 0.66。该公司的债务与股本比率为 0.75，速动比率为 1.03，流动比率为 2.29。</p>
<h2>内部买卖</h2>
<p>在相关消息中，首席执行官 Vivek Jain 在 10 月 1 日星期二出售了 12,000 股公司的股票。该股票以平均价格 178.46 美元出售，总价值为 2,141,520.00 美元。出售完成后，首席执行官现在直接持有 104,593 股公司的股票，价值为 18,665,666.78 美元。这代表其持股减少了 10.29%。该出售在向证券交易委员会提交的文件中披露，相关文件可通过 SEC 网站获取。此外，副总裁 Daniel Woolson 在 8 月 30 日星期五出售了 2,502 股公司的股票。该股票以平均价格 163.22 美元出售，总价值为 408,376.44 美元。出售后，副总裁现在直接持有 13,107 股公司的股票，价值约为 2,139,324.54 美元。这代表其持股减少了 16.03%。该出售的披露信息可以在此找到。在过去三个月中，内部人士出售了 38,502 股公司股票，价值为 6,573,496 美元。6.70% 的股票由公司内部人士持有。</p>
<h2>对 ICU 医疗的对冲基金看法</h2>
<p>一些大型投资者最近调整了他们对 ICU 医疗的持股。SG Americas Securities LLC 在第二季度将其在 ICU 医疗的持股增加了 441.7%。SG Americas Securities LLC 现在持有 5,818 股医疗器械供应商的股票，价值为 691,000 美元，此前在上个季度又购买了 4,744 股。Sei Investments Co.在第一季度将其在 ICU 医疗的持股增加了 52.1%。Sei Investments Co.现在持有 28,586 股医疗器械供应商的股票，价值为 3,068,000 美元，此前在上个季度又购买了 9,793 股。Silvercrest 资产管理集团在第一季度将其在 ICU 医疗的持股增加了 109.4%。Silvercrest 资产管理集团现在持有 278,436 股医疗器械供应商的股票，价值为 29,882,000 美元，此前在上个季度又购买了 145,485 股。先锋集团在第一季度将其在 ICU 医疗的持股增加了 0.5%。先锋集团现在持有 2,452,720 股医疗器械供应商的股票，价值为 263,226,000 美元，此前在上个季度又购买了 11,991 股。最后，Savant Capital LLC 在第二季度收购了 ICU 医疗的新股份，价值为 431,000 美元。96.10% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>关于 ICU 医疗</h2>
<p>（获取免费报告）</p>
<p>ICU 医疗公司及其子公司开发、制造和销售用于输液治疗、血管通路和生命监护应用的医疗设备。其输液治疗产品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的无针产品；Neutron 导管通畅设备；ChemoClave 和 ChemoLock 封闭系统转移设备，用于限制有害药物或蒸汽浓度的逸出，阻止环境污染物进入系统，并消除针刺伤害的风险；Tego 无针连接器；Deltec GRIPPER 非穿刺针用于门静脉通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 ICU 医疗</li>
<li>股息筛选器：如何在购买前评估股息股票</li>
<li>超级微型计算机飙升 28%：它真的走出困境了吗？</li>
<li>股息之王宝洁在财报后疲软时值得买入</li>
<li>交易者纷纷回归石油：是什么推动了乐观情绪</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>3 个热门股票趋势，助力 2025 年</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<p>→ 即使特朗普也无法阻止即将发生的事情。（来自市场背后）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDQ4NA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDQ4NA"/></p>
<h2>你现在应该投资 $1,000 在 ICU 医疗吗？</h2>
<p>在考虑 ICU 医疗之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 ICU 医疗并不在名单上。</p>
<p>虽然 ICU 医疗目前在分析师中获得了 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

ICU医疗

<p>ICU 医疗（NASDAQ:ICUI）被 StockNews.com 从 “持有” 评级上调至 “买入” 评级。其他分析师也给出了不同的评级，Jefferies Financial Group 维持 “持有” 评级，而 KeyCorp 和 Raymond James 则提高了他们的目标价格，并分别给予 “增持” 和 “跑赢大盘” 评级。该股票目前的平均评级为 “适度买入”。最近的内部交易显示，首席执行官 Vivek Jain 和副总裁 Daniel Woolson 出售了股份，减少了他们的持股。对冲基金持有该股票的 96.10%，显示出强烈的机构兴趣</p>

<p>ICU Medical (NASDAQ:ICUI - Get Free Report) was upgraded by StockNews.com from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note issued to investors on Wednesday.</p>
<div class="lb-trans"><p>ICU 医疗（NASDAQ:ICUI - 获取免费报告）在周三发布给投资者的研究报告中，被 StockNews.com 从 “持有” 评级上调至 “买入” 评级。</p>
</div><p>A number of other analysts have also weighed in on the company. Jefferies Financial Group started coverage on ICU Medical in a research note on Monday, October 14th. They issued a &#34;hold&#34; rating and a $183.00 target price on the stock. KeyCorp raised their price objective on ICU Medical from $198.00 to $209.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, November 13th. Needham &amp; Company LLC reissued a &#34;hold&#34; rating on shares of ICU Medical in a report on Wednesday, November 13th. Finally, Raymond James raised their price objective on ICU Medical from $158.00 to $190.00 and gave the stock an &#34;outperform&#34; rating in a research note on Thursday, September 12th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $173.00.</p>
<div class="lb-trans"><p>其他一些分析师也对该公司发表了看法。杰富瑞金融集团在 10 月 14 日星期一发布的研究报告中开始覆盖 ICU 医疗。他们对该股票给予了 “持有” 评级，并设定了 183.00 美元的目标价。KeyCorp 在 11 月 13 日的研究报告中将 ICU 医疗的目标价从 198.00 美元上调至 209.00 美元，并给予该公司 “增持” 评级。Needham &amp; Company LLC 在 11 月 13 日的报告中重新发布了对 ICU 医疗股票的 “持有” 评级。最后，Raymond James 在 9 月 12 日的研究报告中将 ICU 医疗的目标价从 158.00 美元上调至 190.00 美元，并给予该股票 “跑赢大盘” 评级。两位分析师对该股票给予了持有评级，四位分析师则给予了买入评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 173.00 美元。</p>
</div><p><strong>View Our Latest Report on ICUI</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 ICUI 的最新报告</strong></p>
</div><h2>ICU Medical Stock Performance</h2>
<div class="lb-trans"><h2>ICU 医疗股票表现</h2>
</div><p>NASDAQ:ICUI opened at $169.70 on Wednesday. The stock's fifty day moving average is $176.59 and its 200 day moving average is $144.30. ICU Medical has a fifty-two week low of $82.82 and a fifty-two week high of $196.26. The firm has a market capitalization of $4.15 billion, a PE ratio of -37.13 and a beta of 0.66. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.</p>
<div class="lb-trans"><p>NASDAQ:ICUI 在周三开盘价为 169.70 美元。该股票的 50 日移动平均线为 176.59 美元，200 日移动平均线为 144.30 美元。ICU 医疗的 52 周低点为 82.82 美元，52 周高点为 196.26 美元。该公司的市值为 41.5 亿美元，市盈率为-37.13，贝塔值为 0.66。该公司的债务与股本比率为 0.75，速动比率为 1.03，流动比率为 2.29。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In related news, CEO Vivek Jain sold 12,000 shares of the company's stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total value of $2,141,520.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $18,665,666.78. This represents a 10.29 % decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through the SEC website. Also, VP Daniel Woolson sold 2,502 shares of the company's stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $163.22, for a total value of $408,376.44. Following the sale, the vice president now directly owns 13,107 shares of the company's stock, valued at approximately $2,139,324.54. This represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 38,502 shares of company stock valued at $6,573,496 in the last three months. 6.70% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 Vivek Jain 在 10 月 1 日星期二出售了 12,000 股公司的股票。该股票以平均价格 178.46 美元出售，总价值为 2,141,520.00 美元。出售完成后，首席执行官现在直接持有 104,593 股公司的股票，价值为 18,665,666.78 美元。这代表其持股减少了 10.29%。该出售在向证券交易委员会提交的文件中披露，相关文件可通过 SEC 网站获取。此外，副总裁 Daniel Woolson 在 8 月 30 日星期五出售了 2,502 股公司的股票。该股票以平均价格 163.22 美元出售，总价值为 408,376.44 美元。出售后，副总裁现在直接持有 13,107 股公司的股票，价值约为 2,139,324.54 美元。这代表其持股减少了 16.03%。该出售的披露信息可以在此找到。在过去三个月中，内部人士出售了 38,502 股公司股票，价值为 6,573,496 美元。6.70% 的股票由公司内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On ICU Medical</h2>
<div class="lb-trans"><h2>对 ICU 医疗的对冲基金看法</h2>
</div><p>A number of large investors have recently modified their holdings of ICUI. SG Americas Securities LLC grew its holdings in ICU Medical by 441.7% during the 2nd quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock valued at $691,000 after buying an additional 4,744 shares during the last quarter. Sei Investments Co. grew its holdings in ICU Medical by 52.1% during the 1st quarter. Sei Investments Co. now owns 28,586 shares of the medical instruments supplier's stock valued at $3,068,000 after buying an additional 9,793 shares during the last quarter. Silvercrest Asset Management Group LLC grew its holdings in ICU Medical by 109.4% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier's stock valued at $29,882,000 after buying an additional 145,485 shares during the last quarter. Vanguard Group Inc. grew its holdings in ICU Medical by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier's stock valued at $263,226,000 after buying an additional 11,991 shares during the last quarter. Finally, Savant Capital LLC acquired a new stake in ICU Medical during the 2nd quarter valued at $431,000. 96.10% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些大型投资者最近调整了他们对 ICU 医疗的持股。SG Americas Securities LLC 在第二季度将其在 ICU 医疗的持股增加了 441.7%。SG Americas Securities LLC 现在持有 5,818 股医疗器械供应商的股票，价值为 691,000 美元，此前在上个季度又购买了 4,744 股。Sei Investments Co.在第一季度将其在 ICU 医疗的持股增加了 52.1%。Sei Investments Co.现在持有 28,586 股医疗器械供应商的股票，价值为 3,068,000 美元，此前在上个季度又购买了 9,793 股。Silvercrest 资产管理集团在第一季度将其在 ICU 医疗的持股增加了 109.4%。Silvercrest 资产管理集团现在持有 278,436 股医疗器械供应商的股票，价值为 29,882,000 美元，此前在上个季度又购买了 145,485 股。先锋集团在第一季度将其在 ICU 医疗的持股增加了 0.5%。先锋集团现在持有 2,452,720 股医疗器械供应商的股票，价值为 263,226,000 美元，此前在上个季度又购买了 11,991 股。最后，Savant Capital LLC 在第二季度收购了 ICU 医疗的新股份，价值为 431,000 美元。96.10% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>About ICU Medical</h2>
<div class="lb-trans"><h2>关于 ICU 医疗</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.</p>
<div class="lb-trans"><p>ICU 医疗公司及其子公司开发、制造和销售用于输液治疗、血管通路和生命监护应用的医疗设备。其输液治疗产品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的无针产品；Neutron 导管通畅设备；ChemoClave 和 ChemoLock 封闭系统转移设备，用于限制有害药物或蒸汽浓度的逸出，阻止环境污染物进入系统，并消除针刺伤害的风险；Tego 无针连接器；Deltec GRIPPER 非穿刺针用于门静脉通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than ICU Medical</li>
<li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li>
<li>Super Micro Computer Soars 28%: Is It Really Out of the Woods?</li>
<li>Dividend King Proctor &amp; Gamble Is A Buy On Post-Earnings Weakness</li>
<li>Traders Are Flocking Back to Oil: What’s Fueling the Optimism</li>
<li>Earnings Per Share Calculator: How to Calculate EPS</li>
<li>3 Hot Stock Trends to Ride Into 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 ICU 医疗</li>
<li>股息筛选器：如何在购买前评估股息股票</li>
<li>超级微型计算机飙升 28%：它真的走出困境了吗？</li>
<li>股息之王宝洁在财报后疲软时值得买入</li>
<li>交易者纷纷回归石油：是什么推动了乐观情绪</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>3 个热门股票趋势，助力 2025 年</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=ICUI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><p>→ Even Trump can’t stop what’s coming. (From Behind the Markets)(Ad)</p>
<div class="lb-trans"><p>→ 即使特朗普也无法阻止即将发生的事情。（来自市场背后）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDQ4NA" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10484&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in ICU Medical right now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 ICU 医疗吗？</h2>
</div><p>Before you consider ICU Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 ICU 医疗之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 ICU 医疗并不在名单上。</p>
</div><p>While ICU Medical currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 ICU 医疗目前在分析师中获得了 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

ICU 医疗（纳斯达克股票代码：ICUI）在 StockNews.com 被升级为买入评级